share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Li Dean Y

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Li Dean Y

Recursion Pharmaceuticals | 4：持股變動聲明-董事 Li Dean Y
美股sec公告 ·  06/05 18:17
Moomoo AI 已提取核心訊息
Dean Y. Li, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock grant transaction on June 3, 2024. A total of 13,097 shares of Class A Common Stock were acquired at no cost, as part of the grant. Following this transaction, Li directly holds 72,186 shares of the company's stock. Additionally, Li has indirect beneficial ownership of 3,112,844 shares through various trusts, including the Dean Li and Ruth Li Revocable Trust, Dean Y. Li GRAT, and Dean Y. Li 2021 Family Trust.
Dean Y. Li, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock grant transaction on June 3, 2024. A total of 13,097 shares of Class A Common Stock were acquired at no cost, as part of the grant. Following this transaction, Li directly holds 72,186 shares of the company's stock. Additionally, Li has indirect beneficial ownership of 3,112,844 shares through various trusts, including the Dean Li and Ruth Li Revocable Trust, Dean Y. Li GRAT, and Dean Y. Li 2021 Family Trust.
Dean Y. Li與Recursion Pharmaceuticals, Inc. [RXRX]相關，於2024年6月3日完成了股份授予交易。作為授予的一部分，共獲得13,097股A類普通股，並未花費成本。此後，Li直接持有公司股票的72186股。此外，Li通過各種信託間接持有3112844股受益所有權，包括Dean Li和Ruth Li可撤銷信託，Dean Y. Li GRAT和Dean Y. Li 2021家庭信託。
Dean Y. Li與Recursion Pharmaceuticals, Inc. [RXRX]相關，於2024年6月3日完成了股份授予交易。作為授予的一部分，共獲得13,097股A類普通股，並未花費成本。此後，Li直接持有公司股票的72186股。此外，Li通過各種信託間接持有3112844股受益所有權，包括Dean Li和Ruth Li可撤銷信託，Dean Y. Li GRAT和Dean Y. Li 2021家庭信託。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息